Several isoflavonoids, including genistein and daidzein, have bee

Several isoflavonoids, including genistein and daidzein, have been reported to cause inhibition of the Na+-K+-2Cl− cotransporter, as well as an increase in natriuresis and kaluresis.24 Moreover, the flavonoid crisine has been shown to induce a significant increase in urine flow, glomerular filtration and Na+ and K+ excretion. Recently, it was reported that seven methoxy-flavonoids actively bound to adenosine receptor A1, provoking antagonism and therefore dieresis and sodium excretion.25 In the present study, in reference to the elimination of Na+, K+ and Cl−, the extract of G. seemannii Peyr. showed a greater natriuretic

than Epigenetic inhibitor kaluretic effect. The Na+/K+ ratio can define the nature of the diuretic mechanism. The Na+/K+ ratio for furosemide is approximately 1, meaning that it eliminates the two electrolytes equally. On the other hand, with tiacids this ratio is less than one (with a greater excretion of K+ than Na+), and with spironolactone it is greater than one (with a lower excretion of K+ than Na+). 26 There is an association between urine volume and Na+ concentration in the urine. This is logical, considering that the action mechanism of a great number of diuretics on the market is by decreasing the reabsorption of this ion, which induces osmosis Inhibitor Library of water out of the organism.26 The isolation and chemical characterization of the compounds present in different endemic species

of the geranium gender found in the State of Hidalgo, México, showed the presence of tannins and flavonoids, mainly tuclazepam a high percentage of ellagitannins (5–16%),12 The most abundant ellagitannin

is geraniin, described as a crystalizable tannin that was isolated from Geranium thunbergii Sieg et Zucc by Okuda. 27 Hence, tannins are probably responsible for the diuretic effect of G. seemannii Peyr. The present study demonstrates the diuretic activity of the ethanolic extract of G. seemannii Peyr., which increased urinary volume and electrolyte (sodium, potassium and chloride) excretion. The diuretic pattern of the ethanolic extract was similar to that of the reference drug (furosemide), suggesting a similar mechanism of action. Further study of G. seemannii Peyr. is necessary in order to isolate the compounds present in this species, as well as identify which compounds are responsible for the diuretic effect shown by the ethanolic extract. Additionally, it is necessary to determine the mechanism or mechanisms of action involved in the diuretic effect. All authors have none to declare. The authors would like to thank the Universidad Autónoma of the State of Hidalgo and the Instituto Politécnico Nacional for their invaluable support of the present work. We thank Bruce Allan Larsen for reviewing the use of English in the manuscript. “
“Alzheimer’s disease (AD), the most common form of dementia is incurable, degenerative and terminal disease first described by German Neuropathologist, Alois Alzheimer in 1906 and was named after him.

Therefore, the effects of resistance training, either alone or in

Therefore, the effects of resistance training, either alone or in combination with aerobic training, in people with chronic heart failure remain unclear. Therefore the following research BIBW2992 cost questions for this study focused on people with heart failure: 1. Does resistance training

improve heart function, exercise capacity and quality of life in people with chronic heart failure more than no intervention or usual care? Six electronic databases (PubMed, MEDLINE, EMBASE, Chinese Electronic Periodical Service [CEPS], CINAHL, and Cochrane Library Register of Controlled Trials) were searched from the earliest available date until September 2009. We hand-searched reference lists of all identified original articles, previous meta-analyses and reviews. Experts were asked to identify any other relevant trials known to them. The following keywords and Medical Subject Heading (MeSH) terms were used in our searches: heart failure, heart dysfunction, ventricular dysfunction, resistance training, strength exercise, strength training, weight-lifting, and weight

training (see Appendix 1 on the eAddenda for the full search strategy). Published randomised trials limited to human subjects were considered. Articles written in languages other Metabolism inhibitor than English or Chinese were excluded. Two reviewers (CLH and CLC) reviewed the trials using predetermined criteria independently (Box 1). Reviewers were not blinded to authors, place of publication, or results. Design • Randomised trial Participants • Adults with chronic heart failure Intervention • Progressive resistance exercise training, with training defined as a structured, hospital- or home-based program with a target exercise type, intensity, duration and frequency, and with regular measurement of whether these were achieved Outcome measures • Cardiac function Comparisons • Progressive resistance exercise training versus no training or usual care or sham exercise Quality: All trials were critically appraised for methodological quality using the PEDro Scale (0 to 10, Maher et al 2003, de Morton, 2009) by two reviewers (CLH

and CLC). Any disagreements were resolved by discussion with another reviewer (YTW). Participants: Age, gender, Dichloromethane dehalogenase and cause and severity of chronic heart failure were recorded to determine the similarity of participants between groups and between trials. Intervention: The target intensity, duration, and frequency of exercise and the length of the intervention period were recorded. For the study question assessing the effect of resistance training alone, the control was categorised as no intervention, usual activity or sham exercise. For the study question assessing the effect of combined training versus aerobic training alone, the target intensity, duration, and frequency of aerobic exercise were also recorded.

Study of physico–chemical properties

was carried out in o

Study of physico–chemical properties

was carried out in order to standardize the formulations. Generally the formulations may be in the form of solid, liquid or gel. Among these gels formulation is more preferred since it is easy to handle and safe and also have few advantages like they have localized effect with slight side effects.1, 2 and 3 Root canal lubricants in the form of gel were used during root canal lubrication for easier penetration of an instrument in root canal preparation. In order to judge a quality of root canal lubricant it is essential to determine its physico–chemical properties.4 learn more Several experimental studies have indicated that, number INCB024360 chemical structure of generally available lubricants solution or gel is not effective in complete removal of soft and hard organic or inorganic materials at a time.5, 6, 7, 8, 9 and 10 The idea of study of physico–chemical properties came from surface tension of root canal irrigant in order to standardize the formulation.11 Materials required for the study

of physico–chemical properties are purchased from Earth Chemicals, Mumbai made up of Merck Chemicals Pvt. Ltd. The physico–chemical properties of various concentrations of self developed root canal lubricant gel includes appearance, Solid content, 5% aqueous solution pH, moisture content, viscosity and 5% aqueous solution stability in water etc. Appearance of the gel observed physically by eyes. Solid content was determined by heating the gels in an electrical oven. 5% aqueous solution pH was determined using pH metre.

Moisture content in the gel was found out using Karl Fischer’s apparatus. Viscosity was analysed using B. F. Viscometer. The 5% aqueous solution stability is tested in cylinder. The appearance of formulation was observed visually with the help of naked eyes. The formulation is in the form of stable thixotropic gel. It has been observed that, viscosity of gel increases as concentration of active content of gel increases. In order to determine solid content a known quantity of gel was heated in an oven at 110 °C for 3 h or still constant weight is obtained. Exactly 1 g of sample of gel was heated at 110 °C for 3 h or till also constant weight is obtained. The process of heating, cooling and weighing is continued till constant weight is obtained. Loss in weight was determined and from loss in weight, solid content was measured and listed in Table 1 and as shown in Fig. 1. 5% aqueous solution pH of the various concentration of gel was determined using digital pH metre having model no. CL – 280 made up of Labline Technologies Pvt. Ltd. Exactly 2 g self developed root canal lubricant gel was dissolved in 40 ml of distilled water and stored for 3 h.

This was achieved by enhancing the solubility of the lipophilic M

This was achieved by enhancing the solubility of the lipophilic MPTS with the application of FDA approved co-solvents, surfactants and their combinations. The aim of the animal studies was therefore dual as the test not only gave answer

to the in vivo efficacy of the drug candidate drug discovery but would also answer the question of whether the drug shows a fast enough absorption from an intramuscular injection for combating cyanide intoxication. Materials for the conversion test were potassium cyanide (KCN), formaldehyde, ferric nitrate reagent, monobasic sodium phosphate monohydrate and dibasic sodium phosphate anhydrous (VWR International, Suwanee, GA, USA). Methyl propyl trisulfide (50% purity; water solubility = 0.15 ± 0.003 mg/ml) was purchased from Sigma–Aldrich (St. Louis, Missouri, USA), TS were learn more purchased from VWR International (Suwanee, GA, USA). Ethanol, PEG 200, PEG 300, PEG 400, PG (VWR International, Suwanee, GA, USA), Cremophor EL, Cremophor RH40, sodium cholate, sodium deoxycholate, polysorbate 80 (Sigma Aldrich, St. Louis, MO, USA) were used as solubilizers. Cyclohexanone (Sigma–Aldrich, St. Louis, MO, USA) was used as solvent for the GC–MS measurements. KCN solutions (1.0 mg/ml and 3.5 mg/ml) were used throughout the animal studies. 250, 100 and 50 μl Hamilton

Luer-lock syringes (VWR International, Suwanee, GA, USA) were used in the animal studies with 27G 1/2 needles for intramuscular and mafosfamide 25G 1½ needles (VWR International, Suwanee, GA, USA) for subcutaneous injection. In vitro efficacy of MPTS was determined based on

its ability to convert CN to SCN. The method applied was a spectrophotometric measurement of the formed SCN based on the method of Westley (1981) with minor modifications ( Petrikovics et al., 1995). Briefly, 200 μl of various concentrations of SDs, 200 μl of 10 mM phosphate buffered saline, 200 μl of 250 mM KCN and 400 μl of deionized water were mixed. The reaction was incubated for 5 min and was quenched with 500 μl of 15% (v/v) formaldehyde. 1.5 ml of ferric nitrate reagent was added to form a reddish brown complex (Fe(SCN)3) that was quantitatively determined at 464 nm using a spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). Tests were performed with MPTS and TS at concentrations ranging from 25 mM to 0.156 mM with two fold serial dilutions in between. The solubility of MPTS was determined in co-solvents, surfactants and their combinations. Aqueous solutions of co-solvents and surfactants were prepared at 10%, 25%, 50%, 75%, 90% and 1%, 5%, 10%, 15%, 20% respectively. Based on the solubility enhancing efficacy of the co-solvent/water and surfactant/water systems the most effective excipients were combined into one system forming a co-solvent/surfactant/water system.

3, 4 and 5

Studies show that A squamosa L and its activ

3, 4 and 5

Studies show that A. squamosa L. and its active principals possess wide pharmacological actions including antidiabetic, antioxidative, antirheumatic, antilipidemic NVP-BGJ398 datasheet and insecticide. 6, 7, 8, 9 and 10 A fraction of total alkaloid from roots exhibits antihypertensive, antispasmodic, antihistaminic and bronchodilator properties. Leaves contain cardiotonic alkaloids, quinoline, squamone, and bullatacinone were selectively cytotoxic to human breast carcinoma. Two new compounds have been isolated & are reported in this paper which are 5-((6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)-2-methoxybenzene-1,3-diol and (1R,3S)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline-1,3-diol. These compounds are found to be antiulcer in nature. The isolated compounds were evaluated for their activity on Hydrogen Potassium ATPase enzyme and were compared with the omeprazole as the standard drug. Activity was found to be quite comparable. All chemicals used were of analytical grade. Twigs of A. squamosa PFT�� molecular weight (6.0 Kg) were shade dried and finely powdered and placed for maceration with ethanol (18 L) and were kept at room temperature for 48 h. The macerated material was collected. This process of extraction was repeated for five times, till the plant material was extracted exhaustively. The total extract concentrated at 40–45 °C

and weighed. The extract weighed 520 g (8.66%). Ethanolic

extract (500 g) was taken and triturated with n-hexane (250 ml × 15), the hexane fraction concentrated under low pressure at 40 °C. After trituration with hexane the residue was triturated with chloroform until (250 ml × 15), chloroform soluble fraction was evaporated under low pressure; weight of fraction obtained 95 g. After trituration with chloroform, residue was then kept in distilled water (2 L) and then it was fractionated with Aq. saturated n-butanol (500 ml × 10). This fraction was concentrated low pressure at 50 °C (15 g). Aqueous fraction also concentrated under low pressure at 45–50 °C (20 g). Repeated column chromatography was done on chloroform fraction in order to isolate the two new compounds viz. 5-((6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)methyl)-2-methoxybenzene-1,3-diol and (1R,3S)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline-1,3-diol. Melting point for compound no.1 is 194–196 °C, molecular formula is C20H25NO5, m/z obtained at 360.17. Compound no.2 which is characterized as (1R,3S)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinoline-1,3-diol has a melting point range of 124–126 °C, molecular formula is C12H17NO4, m/z obtained at 240.13. The chloroform fraction (95.0 g) was chromatographed on silica gel (60–120 mesh, 900 g), using hexane with increasing amount of chloroform and methanol as eluent.

The methods of the retrieved papers were extracted and reviewed i

The methods of the retrieved papers were extracted and reviewed independently by two reviewers (RS and EP) using predetermined criteria ( Box 1). Disagreement or ambiguities were resolved by consensus after discussion with a third reviewer (LA). Design • Randomised trial or quasi-randomised trial Participants • Adults Intervention • Experimental intervention includes biofeedback using any signal (EMG, force, position) via any sensory system (visual, auditory, tactile) Outcome measures • Measure/s of lower limb activity (sitting, standing up, standing or walking) Quality: The quality of included trials was assessed by extracting PEDro scores from the Physiotherapy Evidence Database. Rating of trials on this database is carried

Smad inhibitor out by two independent trained raters

and disagreements are resolved by a third rater. Where a trial was not included on the database, it was assessed independently by two reviewers who had completed the PEDro Scale training tutorial on the Physiotherapy Evidence Database. Participants: Selleckchem GSK1120212 Trials involving adult participants of either gender, at any level of initial disability, at any time following stroke were included. Age, gender, and time since stroke were recorded to describe the trials. Intervention: The experimental intervention could be of any type of biofeedback, ie, using any signal (position, force, EMG) via any sense (visual, auditory, tactile). At least some of the intervention had to involve practice of the whole activity and practice of the activity had

to involve movement (such as reaching in sitting or weight shift in standing). The control intervention could be nothing, placebo, or usual therapy in any combination. Type of biofeedback, activity trained, and duration and frequency of the intervention were recorded to describe the trials. Outcome measures: Measures of lower limb activity congruent with the activity in which biofeedback was applied were used in the analysis. Where multiple measures for one activity were reported, a measure was chosen that best reflected the aim of the biofeedback intervention Parvulin (eg, step length). The measures used to record outcomes and timing of measurement were recorded to describe the trials. Data were extracted from the included trials by one reviewer and cross-checked by a second reviewer. Information about the method (ie, design, participants, lower limb activity trained, intervention, measures) and data (ie, number of participants and mean (SD) of outcomes) were extracted. Authors were contacted where there was difficulty extracting and interpreting data from the paper. Post-intervention scores were used to obtain the pooled estimate of the effect of intervention in the short term (after intervention) and in the longer term (some time after the cessation of intervention). Since different outcome measures were used, the effect size was reported as Cohen’s standardised mean difference (95% CI). A fixed-effect model was used initially.

In such case, the existence of cavities of very low urodynamic ef

In such case, the existence of cavities of very low urodynamic efficacy, as observed in the present study, were decisive in the formation of such calculi. It is important to emphasize that we observed a thin epithelium covering such cavities (Fig. 3), demonstrating that this epithelium may be formed after the development of the calculi through a re-epithelialization process. The re-epithelialization is a posterior process of an epithelial lesion, it finalizes with the formation

of a scarring. The scar formation consists in the proliferation in all directions of epithelial cell rest present in inflamed lesions that form strands or islands of epithelium, which then are invaded by vascular fibrous connective tissue. The existence of COD calculi can be explained this website considering that because of the elevated calcium concentrations detected in urine of 24 hours, this must involve periods of higher values (formation of COD) and periods with low values (formation of COM). It is interesting that almost all stones developed in the same kidney (right). This clearly implies morphoanatomic

differences between the 2 kidneys in such manner that one exhibits a complex internal structure with presence of narrow cavities of low urodynamic efficacy. This demonstrates the importance of morphoanatomy as a factor involved in lithogenesis. No similar cases have been previously click here described in the literature. This work was supported by the project CTQ2010-18271 from the Ministerio de Ciencia e Innovación (Gobierno de España), FEDER funds (European Union) and Mephenoxalone the project grant 9/2011 from the Conselleria d’Educació, Cultura i Universitat (Govern

de les Illes Balears). “
“Historically, those who had penile amputation have been pushed toward gender reassignment surgery because of the poor outcomes of historic attempts at phalloplasty.1 Since the first radial artery free flap (RAFF) phalloplasty technique was performed in 1984, the number of patients with full phalloplasty has been rising, and the challenges and complications of treatment within this patient population have become worthy of study. The use of hair-bearing skin for the phalloplasty carries extra complications because of the introduction of skin epithelial elements into a previously urothelium-exclusive environment. These patients are generally followed up very closely, as the complications of such a major surgery are frequent and often requiring quick correction.2 and 3 We present a case of a patient who presented after >2 years of no follow-up for complications of his procedure. The patient is a 35-year-old male with a past medical history of assault with traumatic amputation of penis and testicles in February 2011. The patient had no other medical, surgical, or social history. In May 2011 a RAFF phalloplasty was performed. Patient course after initial repair was complicated by wound dehiscence and fistula formation with stricturing.

6 The pure drug tinidazole Fig  6(a)

gives rise to a sha

6. The pure drug tinidazole Fig. 6(a)

gives rise to a sharp peak that corresponds to melting point at 126 °C, indicates its crystalline nature. The pure polymer Eudragit L 100 and Eudragit S 100 exhibits a peak at 223 °C and 222 °C respectively, referring to the relaxation that follows the glass transition in Fig. 6 (b) and (c). The peak of drug did not appear in the thermogram of prepared microspheres, Dorsomorphin molecular weight it may indicate the drug was uniformly dispersed at the molecular level in the microspheres in Fig. 6 (d). From the result of present study, it can be concluded that Eudragit based tinidazole microspheres offer a high degree of protection from premature drug release in simulated upper GIT conditions and deliver most of the drug load in the colon and allow drug release to occur at the desired site by emulsion solvent evaporation system. A factorial method was used

in the study. Based on the results of the physicochemical characterization and in vitro drug release studies, it possessed all the required physicochemical characters and with drug releases up to 8 h where it released 92% of the tinidazole. Thus, Eudragit based tinidazole microspheres are a potential system for colon delivery of tinidazole for chemotherapy of amoebic infection. All authors have none to declare. Authors are thankful to MET’s Institute of Pharmacy, Bhujbal Knowledge City, Adgaon, Nasik for providing necessary facilities to carry out this work. Authors are sincerely thankful to Sophisticated Test and Etomidate Instrumentation Center (STIC, Cochin, India) for providing facilities for SEM in AZD6244 mouse sampling. “
“Diabetes mellitus (DM) is a chronic disease caused by inherited or acquired deficiency in insulin secretion and by decreased responsiveness of the organs to secreted insulin.1 Diabetes mellitus is a syndrome, initially characterized by a loss of glucose homeostasis resulting from

defects in insulin secretion, insulin action both resulting impaired metabolism of glucose and other energy yielding fuels such as lipids and proteins.2 DM is a leading cause of end stage kidney disease, cardiomyopathy and heart attacks, strokes, retinal degeneration leading to blindness and non-traumatic amputations.3 Dyslipidemia, quite common in diabetic patients, is the main risk factor for cardiovascular and cerebrovascular diseases. DM is currently one of the most costly and burdensome chronic diseases and is a condition that is increasing in epidemic proportions throughout the world. Diabetes is a serious illness with multiple complications and premature mortality, accounting for at least 10% of total health care expenditure in many countries.4 The prevalence of diabetes of all age groups worldwide is projected to rise from 171 million in 2000 to 366 million in 2030.5 Reason of this rise includes increase in sedentary life style, consumption of energy rich diet, obesity, higher life span, etc.

Cases were categorized by health status: cases that were otherwis

Cases were categorized by health status: cases that were otherwise healthy, cases with underlying health conditions that are an indication for seasonal influenza vaccination and cases with underlying health conditions that are not an indication for seasonal influenza vaccination. Health conditions for which vaccine is recommended include chronic heart disease, chronic lung disease (including asthma), diabetes mellitus or other Buparlisib research buy metabolic disorder, cancer, immunodeficiency, immunosuppression, chronic renal disease, anemia, hemoglobinopathy, chronic acetylsalicylic acid therapy, residence in institutional setting,

and health conditions that can compromise respiratory function or increase risk of aspiration [11]. Canadian and American guidelines indicate that these conditions also confer higher risk for adverse outcomes with pandemic H1N1 [12] and [13]. Risk factors, hospital course, outcome and antiviral use were examined for pandemic H1N1 cases. SAS version 9.1.3 (SAS Institute, Cary, NC) was used for all analyses. From May 1, 2009 to August 31, 2009 a total of 324 influenza A cases was reported, as shown in Fig. 1. Pandemic H1N1 Olaparib manufacturer was identified as the subtype in 98.5% of the reported cases; the remainder of the influenza A cases (n = 5) had no subtype information available at the time of our report. The spring wave had a sharp peak with 74.4% of cases occurring

in a 5-week period. Peak hospitalizations occurred during the week of June 13, 2009. Case details were complete for 235 of the 324 cases (73%), with the majority of centers (9/12) having completed Tolmetin detailed reporting on >80% of their cases by August 31, 2009. Details on the 235 completed cases are described below. The last reported case in this series occurred the week of August 17. Fig. 2 shows the age distribution by health status of pandemic cases. The median age of the 235 cases was 4.8 years (range 0–16 years) with 162 children (69%) over the age of 2. Males comprised 55% of cases. Ethnicity data were available on 56% of the cases;

7.2% were First Nations/Aboriginal. In total, 95 (40%) of children were previously healthy. The proportion with at least one underlying health condition increased with age; 33% (24/73) of children under age two had health conditions, compared to 72% (116/162) of children ≥2 years old (Fig. 2). Overall, 121 children (51%) had an underlying health condition for which seasonal influenza vaccine is recommended and of those, 102 were ≥2 years old. Table 1 describes the number and type of underlying conditions. Chronic lung disorders was the largest category (almost 25%) consisting primarily of asthma (n = 37), broncho-pulmonary dysplasia (n = 6) and cerebral palsy with chronic aspiration (n = 5). The majority of children had fever (215, 92%) and cough (213, 91%).

Une synthèse des recommandations actuelles concernant l’activité

Une synthèse des recommandations actuelles concernant l’activité sexuelle chez les patients cardiaques est disponible en complément électronique. La réadaptation cardiaque permet d’optimiser la prévention secondaire et la prise en charge des facteurs de risque, et l’activité physique a des effets favorables sur la maladie cardiovasculaire elle-même ainsi que sur la capacité physique et donc la diminution des risques cardiovasculaires lors de l’activité sexuelle. Un des points absolument essentiel dans les relations entre patient et médecin, au regard de l’activité sexuelle, est de pouvoir

échanger sur le sujet. En effet, les patients, très souvent, ne décrivent pas leur problème d’activité sexuelle à leur médecin ou à leur cardiologue. Dans une série concernant 1455 hommes de 55 à 87 ans [37] and [38]

aux États-Unis, seuls 38 % des patients ayant des troubles de la fonction sexuelle selleck chemicals llc ont évoqué click here le sujet avec leur médecin au-delà de l’âge de 50 ans. Dans cette série, près de 15 % des hommes prenaient des médicaments pour leur dysfonction érectile non prescrits par leur médecin. Une petite série concernant un faible nombre d’hommes et de femmes apportent néanmoins un éclairage intéressant sur cette dimension [39]. L’activité sexuelle la plus fréquemment pratiquée dans cette série concernant des patients de plus de 70 ans était pour les hommes des relations sexuelles classiques et pour les femmes la masturbation. Les troubles de la fonction sexuelle rapportés étaient pour les hommes principalement la dysfonction érectile et pour les femmes un manque de désir ou d’intérêt pour l’activité sexuelle. Parmi les sujets ayant des troubles de la fonction sexuelle, seuls 4 % des femmes et 36 % des hommes ont pris l’initiative d’évoquer leurs unless difficultés avec leur médecin. Le plus grave est que la discussion sur le sujet n’a été initiée par le médecin lui-même que pour 7 % des femmes et 32 % des hommes,

alors même que, très souvent, les patients souhaitent que ce soit le médecin qui prenne l’initiative (32 % des femmes et 86 % des hommes). On voit bien ici le déficit de communication sur ce sujet et c’est sans doute au médecin de prendre l’initiative et d’évoquer, à titre systématique, les éventuels problèmes de fonction sexuelle chez les patients cardiaques. L’activité sexuelle est donc l’un des éléments essentiel de la qualité de vie chez les patients cardiaques. Celle-ci est fréquemment altérée chez les hommes dans la mesure où la prévalence de la dysfonction érectile est élevée et augmente avec l’âge, l’élément cardinal étant la dysfonction endothéliale fortement liée aux facteurs de risque cardiovasculaires et à l’athérome. Une prise en charge pluridisciplinaire au sein d’une équipe comportant psychologue et urologue est indispensable car la dimension psychologique est souvent ici essentielle.